Detalhe da pesquisa
1.
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
J Allergy Clin Immunol
; 131(2): 461-7.e1-5, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23040887
2.
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
N Engl J Med
; 358(12): 1215-28, 2008 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18344568
3.
Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone.
Am J Clin Dermatol
; 8(2): 93-102, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17428114